Drugs Made In America Acq...

NASDAQ: DMAA · Real-Time Price · USD
10.27
-0.01 (-0.10%)
At close: Aug 15, 2025, 3:56 PM
10.27
0.00%
After-hours: Aug 15, 2025, 04:00 PM EDT

Drugs Made In America Acquisition Ordinary Shares Cash Flow Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024
Net Income
1.11M -145.26K -144.98K -54.93
Depreciation & Amortization
n/a n/a n/a n/a
Stock-Based Compensation
n/a n/a n/a n/a
Other Working Capital
-2.63K 67.47K 67.34K -60
Other Non-Cash Items
-1.47M 20.33K 20.3K -0.00
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
52.57K 67.47K 67.34K -60
Operating Cash Flow
-308.71K -57.47K -57.34K -114.93
Capital Expenditures
n/a n/a n/a n/a
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
-231.15M n/a n/a n/a
Investing Cash Flow
-231.15M n/a n/a n/a
Debt Repayment
-582.88K 317.13K 317.13K n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
338.01K 87.19K 87.19K 133.03
Financial Cash Flow
231.44M 40.72K 41.36K 133.03
Net Cash Flow
-17.16K -16.73K -15.98K 18.10
Free Cash Flow
-308.71K -57.47K -57.34K -114.93